NeuroDex specializes in biotechnology, focusing on precision medicine for neurodegenerative diseases. The company is pioneering the development of innovative biomarkers to effectively identify patients with synucleinopathies, including Alzheimer's, thereby enhancing diagnosis and treatment strategies in the medical devices and equipment industry.
Massachusetts, • United States
California, • United States
Basel-City, • Switzerland
New Jersey, • United States
California, • United States
Massachusetts, • United States